Literature DB >> 24083766

Lgr4 promotes glioma cell proliferation through activation of Wnt signaling.

Chun-Yong Yu1, Guo-Biao Liang, Peng Du, Yun-Hui Liu.   

Abstract

The key signaling networks regulating glioma cell proliferation remain poorly defined. The leucine-rich repeat containing G-protein coupled receptor 4 (Lgr4) has been implicated in intestinal, gastric, and epidermal cell functions. We investigated whether Lgr4 functions in glioma cells and found that Lgr4 expression was significantly increased in glioma tissues. In addition, Lgr4 overexpression promoted while its knockdown using small interfering RNA oligos inhibited glioma cell proliferation. In addition, Wnt/β-catenin signaling was activated in cells overexpressing Lgr4. Therefore, our results revealed that Lgr4 activates Wnt/β-catenin signaling to regulate glioma cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24083766     DOI: 10.7314/apjcp.2013.14.8.4907

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

1.  Overexpression of Notch1 is associated with the progression of cervical cancer.

Authors:  Yan Sun; Rui Zhang; Shujuan Zhou; Yuqiang Ji
Journal:  Oncol Lett       Date:  2015-04-23       Impact factor: 2.967

2.  LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.

Authors:  Zhiying Yue; Zengjin Yuan; Li Zeng; Ying Wang; Li Lai; Jing Li; Peng Sun; Xiwen Xue; Junyi Qi; Zhengfeng Yang; Yansen Zheng; Yuanzhang Fang; Dali Li; Stefan Siwko; Yi Li; Jian Luo; Mingyao Liu
Journal:  FASEB J       Date:  2017-12-21       Impact factor: 5.191

3.  RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminoma.

Authors:  Christine Hjorth Andreassen; Mette Lorenzen; John E Nielsen; Sam Kafai Yahyavi; Birgitte Grønkær Toft; Lars R Ingerslev; Christoffer Clemmensen; Lene Juel Rasmussen; Carsten Bokemeyer; Anders Juul; Anne Jørgensen; Martin Blomberg Jensen
Journal:  Br J Cancer       Date:  2022-04-13       Impact factor: 9.075

Review 4.  WNT signaling in glioblastoma and therapeutic opportunities.

Authors:  Yeri Lee; Jin-Ku Lee; Sun Hee Ahn; Jeongwu Lee; Do-Hyun Nam
Journal:  Lab Invest       Date:  2015-12-07       Impact factor: 5.662

Review 5.  The Role of LGR4 (GPR48) in Normal and Cancer Processes.

Authors:  Alejandro Ordaz-Ramos; Victor Hugo Rosales-Gallegos; Jorge Melendez-Zajgla; Vilma Maldonado; Karla Vazquez-Santillan
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

6.  G-protein coupled receptor 34 knockdown impairs the proliferation and migration of HGC-27 gastric cancer cells in vitro.

Authors:  Zhong-Tian Jin; Kun Li; Mei Li; Zhi-Gang Ren; Fu-Shun Wang; Ji-Ye Zhu; Xi-Sheng Leng; Wei-Dong Yu
Journal:  Chin Med J (Engl)       Date:  2015-02-20       Impact factor: 2.628

7.  Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.

Authors:  Hans-Juergen Schulten; Deema Hussein
Journal:  PLoS One       Date:  2019-05-13       Impact factor: 3.240

Review 8.  Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classification.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Biomedicines       Date:  2021-05-30

9.  Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.

Authors:  Joana Vieira de Castro; Eduardo D Gomes; Sara Granja; Sandra I Anjo; Fátima Baltazar; Bruno Manadas; António J Salgado; Bruno M Costa
Journal:  J Transl Med       Date:  2017-10-02       Impact factor: 5.531

10.  TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas.

Authors:  Giovanna Casili; Maria Caffo; Michela Campolo; Valeria Barresi; Gerardo Caruso; Salvatore M Cardali; Marika Lanza; Raffaella Mallamace; Alessia Filippone; Alfredo Conti; Antonino Germanò; Salvatore Cuzzocrea; Emanuela Esposito
Journal:  Oncotarget       Date:  2018-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.